Greater Cannabis Company (GCAN) Income from Continuing Operations (2017 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Income from Continuing Operations of 33376.0 in Q1 2026, down 109.88% quarter-over-quarter from 337757.0 in Q4 2025, and up 67.76% on a YoY basis from 19895.55 in Q1 2025.
Greater Cannabis Company (GCAN) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 33376.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 67.76% year-over-year to 33376.0; the TTM figure through Mar 2026 stood at 122571.0 (up 48.49% YoY), while the FY2025 annual figure was 331612.0, down 85.22% from the prior year.
- Income from Continuing Operations was 33376.0 for Q1 2026 at Greater Cannabis Company, down from 337757.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 337757.0 in Q4 2025 to a low of 390853.0 in Q2 2025.
- Historically, Income from Continuing Operations has averaged 56105.47 across 5 years, with a median of 46165.0 in 2024.
- Biggest YoY gain for Income from Continuing Operations was 879.18% in 2025; the steepest drop was 770.17% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 47401.0 in 2022, then gained by 1.14% to 46861.0 in 2023, then rose by 7.5% to 43348.0 in 2024, then soared by 879.18% to 337757.0 in 2025, then sank by 109.88% to 33376.0 in 2026.
- The last three Income from Continuing Operations figures came in at 33376.0 (Q1 2026), 337757.0 (Q4 2025), and 36099.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Greater Cannabis Company | - | - | - | -33,376.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33,376.00 |
| Dec 31, 2025 | 337,757.00 |
| Sep 30, 2025 | -36,099.00 |
| Jun 30, 2025 | -390,853.00 |
| Mar 31, 2025 | -103,511.00 |
| Dec 31, 2024 | -43,348.00 |
| Sep 30, 2024 | -46,165.00 |
| Jun 30, 2024 | -44,917.00 |
| Mar 31, 2024 | -44,611.00 |
| Dec 31, 2023 | -46,861.00 |
| Sep 30, 2023 | -53,430.00 |
| Jun 30, 2023 | -45,043.00 |
| Mar 31, 2023 | -43,068.00 |
| Dec 31, 2022 | -47,401.00 |
| Sep 30, 2022 | -102,776.00 |
| Jun 30, 2022 | -62,405.00 |
| Mar 31, 2022 | -147,686.00 |
| Dec 31, 2021 | -196,331.00 |
| Sep 30, 2021 | -252,278.00 |
| Jun 30, 2021 | -38,964.00 |